mRNA

Zhimei Jiang1, Yanhua Xu2, Guangsheng Du2

  • 1Department of Pharmacy, Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University, Chengdu 610041, China.

概括

使者RNA (mRNA) 纳米疫苗,基于脂质纳米粒子 (LNP) 的成功,显示了癌症疫苗接种的前景. 这些先进的传递系统通过改善mRNA稳定性,细胞吸收和免疫细胞向来增强抗瘤免疫力.